|
14 Aug 2019 |
Bio-Thera Solutions Initiates Phase I Clinical Trial for BAT2506, a Proposed Biosimilar of Simponi® (Golimumab)
|
|
14 Aug 2019 |
Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease
|
|
13 Aug 2019 |
Lilly Announces Superiority of Taltz® (ixekizumab) versus TREMFYA® (guselkumab) in Delivering Total Skin Clearance at Week 12 in Topline Results from Head-to-Head (IXORA-R) Trial in People Living with Moderate to Severe Plaque Psoriasis
|
|
13 Aug 2019 |
Terns Pharmaceuticals Announces Positive Interim Results From Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH
|
|
13 Aug 2019 |
Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
|
|
13 Aug 2019 |
Janssen Announces European Commission Approval of Imbruvica® (ibrutinib) for Expanded Use in Two Indications
|
|
13 Aug 2019 |
Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors
|
|
13 Aug 2019 |
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
|
|
13 Aug 2019 |
Kiniksa Announces Interim Data from KPL-716 Repeated-Single-Dose Phase 1b Clinical Trial
|
|
13 Aug 2019 |
Basilea starts phase 1/2 study with derazantinib in urothelial cancer
|
|
13 Aug 2019 |
ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)
|
|
13 Aug 2019 |
Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.
|
|
13 Aug 2019 |
Pharming acquires exclusive license to CDZ173, a late stage drug for the treatment of APDS
|
|
12 Aug 2019 |
Ridgeback Biotherapeutics LP announces an update on mAb114, an experimental treatment for Ebola
|
|
12 Aug 2019 |
First Patient Enrolled in Mallinckrodt's Phase 2a Study of Investigational Drug MNK-6106 in Hepatic Cirrhosis and Chronic Hepatic Encephalopathy (HE)
|
|
12 Aug 2019 |
PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths
|
|
12 Aug 2019 |
Kedrion Biopharma Announces First Patient Enrolled in CARES10, a Phase 3, Multi-Center Study to Assess a 10 Percent Intravenous Immunoglobulin in Adults with Primary Immunodeficiency Disease
|
|
12 Aug 2019 |
TScan Therapeutics Announces Pioneering Publication in Scientific Journal Cell Describing New Methods to Identify Targets for T Cell Receptor Immunotherapy
|
|
12 Aug 2019 |
Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies
|
|
12 Aug 2019 |
Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial of IMU-838 for the Treatment of Patients with Primary Sclerosing Cholangitis
|
